Nothing Special   »   [go: up one dir, main page]

MX2007010703A - Composiciones antifungicas. - Google Patents

Composiciones antifungicas.

Info

Publication number
MX2007010703A
MX2007010703A MX2007010703A MX2007010703A MX2007010703A MX 2007010703 A MX2007010703 A MX 2007010703A MX 2007010703 A MX2007010703 A MX 2007010703A MX 2007010703 A MX2007010703 A MX 2007010703A MX 2007010703 A MX2007010703 A MX 2007010703A
Authority
MX
Mexico
Prior art keywords
hydrocortisone
sertaconazol
quinolone compound
antifungal compositions
antibacterial quinolone
Prior art date
Application number
MX2007010703A
Other languages
English (en)
Inventor
Jesus Torres
Manuel M Raga
Celia Palacin
Marta Guerrero
Antonio Guglietta
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of MX2007010703A publication Critical patent/MX2007010703A/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J1/00—Details of electrodes, of magnetic control means, of screens, or of the mounting or spacing thereof, common to two or more basic types of discharge tubes or lamps
    • H01J1/02—Main electrodes
    • H01J1/30—Cold cathodes, e.g. field-emissive cathode

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Manufacturing & Machinery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

La invencion se refiere a composiciones farmaceuticas utiles para el tratamiento de enfermedades dermicas causadas por hongos y levaduras con inflamacion y/o asociadas a una infeccion bacteriana . Dichas composiciones contienen una cantidad terapeuticamente efectiva de sertaconazol, o sus sales, solvatos, isomeros farmaceuticamente aceptables o las mezclas correspondientes; y una cantidad terapeuticamente efectiva de al menos un compuesto seleccionado entre hidrocortisona, un ester de hidrocortisona farmaceuticamente aceptable, un compuesto de quinolina antibacteriano o las mezclas correspondientes.
MX2007010703A 2005-03-01 2006-02-22 Composiciones antifungicas. MX2007010703A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05101540A EP1698336A1 (en) 2005-03-01 2005-03-01 Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent
PCT/EP2006/060190 WO2006092374A1 (en) 2005-03-01 2006-02-22 Antifungal compositions comprising sertaconazol and hydrocortisone and/or an antibacterial quinolone compound

Publications (1)

Publication Number Publication Date
MX2007010703A true MX2007010703A (es) 2007-10-12

Family

ID=34938848

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007010703A MX2007010703A (es) 2005-03-01 2006-02-22 Composiciones antifungicas.

Country Status (16)

Country Link
US (1) US20080166398A1 (es)
EP (2) EP1698336A1 (es)
JP (1) JP2008531640A (es)
KR (1) KR20070107806A (es)
CN (1) CN101137362A (es)
AR (1) AR053688A1 (es)
AU (1) AU2006219903A1 (es)
BR (1) BRPI0607561A2 (es)
CA (1) CA2598598A1 (es)
MX (1) MX2007010703A (es)
NO (1) NO20074945L (es)
PE (1) PE20061241A1 (es)
RU (1) RU2007136169A (es)
TW (1) TW200640452A (es)
UY (1) UY29402A1 (es)
WO (1) WO2006092374A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8057433B2 (en) 2004-07-08 2011-11-15 Drugtech Corporation Delivery system
US20110212933A1 (en) * 2008-03-20 2011-09-01 Allan Shapiro Antiseptic Compositions for the Treatment of Infections
EP2177208A1 (en) * 2008-10-17 2010-04-21 Ferrer Internacional, S.A. Pharmaceutical topical compositions
CN103156862B (zh) * 2013-03-28 2015-04-29 孙国栋 一种复方伏立康唑滴耳剂及其制备方法
WO2016129657A1 (ja) * 2015-02-13 2016-08-18 マルホ株式会社 ピリドンカルボン酸系誘導体を含有する外用剤
MX2018015637A (es) * 2016-07-08 2019-06-17 Acraf Composicion farmaceutica que comprende bencidamina.
CN113520993B (zh) * 2021-07-30 2022-07-29 海南海神同洲制药有限公司 一种低粘度硝酸舍他康唑乳膏的制备方法及其制备的产品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407663A (en) * 1991-04-11 1995-04-18 Eisen; Drore Method of treating inflammatory conditions of the mouth using steroid containing mouthwash which may contain antifungal agents
US5578315A (en) * 1993-12-01 1996-11-26 Rutgers, The State University Of New Jersey Mucosal adhesive device for long-acting delivery of pharmaceutical combinations in oral cavity
EP1070713B1 (en) * 1998-04-06 2006-10-18 Toyama Chemical Co., Ltd. Quinolonecarboxylic acid derivatives or salts thereof
ATE352292T1 (de) * 2001-09-04 2007-02-15 Trommsdorff Arzneimittel Pflaster mit sertaconazol zur behandlung von nagelfunktionsstörungen und erkrankungen
US20030091540A1 (en) * 2001-10-16 2003-05-15 Nawaz Ahmad Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity
ES2203316B1 (es) * 2002-02-11 2005-03-01 Ferrer Internacional, S.A. R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol.
US20040176337A1 (en) * 2002-12-31 2004-09-09 Wockhardt Limited Benzoquinolizine-2-carboxylic acid-containing compositions
PL2106805T3 (pl) * 2003-03-21 2011-10-31 Nexmed Holdings Inc Przeciwgrzybicza powłoka na paznokcie

Also Published As

Publication number Publication date
NO20074945L (no) 2007-11-21
WO2006092374A1 (en) 2006-09-08
AU2006219903A1 (en) 2006-09-08
KR20070107806A (ko) 2007-11-07
TW200640452A (en) 2006-12-01
CA2598598A1 (en) 2006-09-08
PE20061241A1 (es) 2006-11-13
US20080166398A1 (en) 2008-07-10
RU2007136169A (ru) 2009-04-10
EP1858510A1 (en) 2007-11-28
AR053688A1 (es) 2007-05-16
CN101137362A (zh) 2008-03-05
JP2008531640A (ja) 2008-08-14
UY29402A1 (es) 2006-06-30
EP1698336A1 (en) 2006-09-06
BRPI0607561A2 (pt) 2009-09-15

Similar Documents

Publication Publication Date Title
MX2007010703A (es) Composiciones antifungicas.
ECSP077239A (es) Formulación farmacéutica
WO2004062601A3 (en) Antibacterial agents
WO2012032360A3 (en) Novel use
WO2003091276A3 (en) Compositions and methods of use of peptides in combination with biocides and/or germicides
WO2018208985A3 (en) Antibacterial compounds
WO2008154642A3 (en) Antibacterial agents
EP2279662A3 (en) 5,7,4'-trihydroxy-3',5'-dimethoxyflavone as an antibacterial agent
WO2007130655A3 (en) Phage derived antimicrobial activities
WO2007134777A3 (de) Fungizide wirkstoffkombinationen
EP2023724B8 (de) Synergistische wirkstoffkombinationen
EP2889034A3 (en) Compositions and methods of treatment comprising ceftaroline
WO2009038412A3 (en) Beta-secretase inhibiting compounds
WO2007064620A3 (en) Compositions comprising a combination of ccr5 and cxcr4 antagonists
EP4014000A4 (en) MICROBIAL COMPOSITIONS FOR PREVENTING OR REDUCING THE GROWTH OF FUNGAL PATHOGENS ON PLANTS
WO2007138112A3 (en) Compounds that interact with ion channels, in particular with ion channels from the kv family
WO2010036000A3 (en) Novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone and pharmaceutical compositions thereof
MY136090A (en) Fungicidal composition based on a pyridylmethylbenzamide derivative and a valinamide drivative
AR064152A1 (es) Derivados de quinolina antibacterianos,composiciones farmaceuticas que los contienen y metodo de preparacion.
WO2011042473A3 (en) Estrogen receptor ligands
WO2007134776A3 (de) Fungizide wirkstoffkombinationen
EP4166155A4 (en) COMPOSITION COMPRISING A PENTAPEPTIDE AS ACTIVE PRINCIPLE
WO2010030811A3 (en) CARBACEPHEM β-LACTAM ANTIBIOTICS
WO2009038411A3 (en) Beta-secretase inhibiting compounds having oxo-dihydro-pyrazole moiety
WO2007047881A3 (en) Method for treating neuropathic pain

Legal Events

Date Code Title Description
FA Abandonment or withdrawal